Complete Revascularization Lowers CV Death Risk Compared to Culprit-Only Stenting in Heart Attack Patients: Study

The results were published simultaneously in The Lancet and presented in a Late-Breaking Clinical Science Featured Research Session at the American Heart Association’s 2025 Scientific Sessions in New Orleans, Louisiana, on November 9, 2025.

“Cardiologists face a dilemma when a patient has a heart attack and multiple coronary artery blockages are found: should they treat only the culprit artery causing the acute heart attack, or perform complete revascularization and open all blocked arteries, including the bystander arteries?” said Shamir R. Mehta, study chair, PHRI senior scientist, interventional cardiologist at McMaster University. “Previous randomized trials suggested that complete revascularization reduced non-fatal heart events, but there was uncertainty as to whether it also lowers death from cardiovascular causes, the most important outcome. By combining data from several large trials, we finally had enough patients to clearly answer that question.”

The study analyzed data from six international multicentre randomized clinical trials enrolling 8,836 heart attack patients with a median age of 65.8 years, including 2,122 women and 6,714 men.

Over a three-year follow-up period, patients who received complete revascularization (i.e., stenting of the culprit and all bystander blockages) were less likely to experience death from cardiovascular causes or a new heart attack compared with those treated with only opening the culprit artery. In addition, there was a lower risk of death from any cause.

Patients who received complete revascularization with stents had a one-quarter lower rate of cardiovascular death or new heart attack, 9.0 per cent compared with 11.5 per cent in those treated with stents to the culprit artery only. Cardiovascular deaths were 3.6 per cent versus 4.6 per cent, a 24 per cent relative reduction and all-cause deaths were 7.2 per cent versus 8.1 per cent, a 15 per cent relative reduction. New myocardial infarctions were also reduced, while non-cardiovascular deaths (such as death due to cancer or infection) were similar between the groups.

The benefits of complete revascularization were seen in patients presenting with both STEMI (ST-segment elevation myocardial infarction or full-blown heart attacks caused by complete blockage of the culprit artery) and NSTEMI (non-ST-segment elevation myocardial infarction, smaller heart attacks caused by severe partial blockage of the culprit artery), as well as in younger and older patients. These improvements were observed in addition to proven heart treatments, including blood thinners such as dual antiplatelet therapy, statins, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, and beta-blockers.

“By reducing pre-mature death, this large international study takes the importance of complete revascularization for patients having a heart attack to a different level. It firmly establishes complete revascularization as one of the very few life-saving procedures cardiologists now have that not only prevents future heart attacks but now also prolongs life. That’s a major advance that has widespread implications,” said Mehta.

Reference: Prof Shamir R Mehta, Denise T W Tiong, Felix Böhm, Chinthanie Ramasundarahettige, Prof Simone Biscaglia, Prof Gianluca Campo, Prof Stefan James, Prof Pieter C Smits, Daniele Giacoppo, Prof Gerry P McCann, Amerjeet Banning, Dan Eik Høfsten, Gianni Casella, Faith R Kirabo, Helen Nguyen, Prof David A Wood, Prof John A Cairns, Prof Thomas Engstrøm; Opening all blocked arteries with stents reduces risk of death from cardiovascular causes compared with opening only the culprit artery in heart attack patients; McMaster University; Journal: The Lancet; DOI 10.1016/S0140-6736(25)02170-1